COBENFY™ (xanomeline and trospium chloride) is a prescription medicine used to treat schizophrenia in adults. It is not known ...

Doctors say the studies may make healthcare providers more likely to prescribe federally approved medical cannabis for ...

Chronic constipation is more than just the occasional “off” day in the bathroom. It’s when going becomes difficult, ...

Occasional constipation is common, but doctors warn that constipation lasting for months may signal colon cancer, especially ...

Cascara may not be as eye-catching or valuable for timber as other notable Pacific Northwest trees, such as Douglas-fir and ...

The countdown is over and the New Year 2026 is finally here. No one is judging you if you partied a bit hard as you stepped ...

Ginger can be added to drinks, smoothies, and soups to enhance the gut-friendly benefits. Experts also recommend pairing ...

Did you miss the most popular gastroenterology stories this year? Medscape Medical News tracked the news most popular with ...

Instead of giving up wine and cigarettes, W's wellness columnist tries a holistic treatment, rectal insufflation, to fix her ...

As of Friday, January 02, Ironwood Pharmaceuticals, Inc.’s IRWD share price has surged by 60.00%, which has investors ...

Changes are coming in 2026 for GLP-1 drugs. Long defined by high prices, shortages and weekly injections, drugs including ...

At the same time, Ironwood backed its 2025 outlook for adjusted Ebitda of more than $135 million on revenue of $290 million to $310 million. For the current year, Linzess sales are expected to come in ...